Pharmafile Logo
Pharmafocus logo
Advanced Search

women’s health

Showing 8 posts of 8 posts found.

Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology

July 29, 2025
Medical Communications, Research and Development Open Quantum Institute, Pain, Reproductive health, UN Sustainable Development Goals, United Nations, Universal Quantum, endometriosis, women's health

Based in Brighton, UK, Universal Quantum has joined the Open Quantum Institute (OQI) to explore how quantum computing could revolutionise …

News

Theramex receives recommendation for YSELTY in Scotland

November 11, 2024
Research and Development Pain, Reproductive health, appproval, tumours, women's health

Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …

News

Janssen’s study for nipocalimab as indicated for EOS-HDFN published in The New England Journal of Medicine

August 9, 2024
Research and Development Haematology, Janssen, New England Journal of Medicine, Obstetrics & Gynaecology, foetus, newborn, women's health

Johnson & Johnson company Janssen has announced that the results from its phase 2 trial into nipocalimab have been published …

News

An overview of women’s health in 2024

April 9, 2024
Reproductive health, abortion, fertility, reproductive health, women's health

Betsy Goodfellow from Pharmafocus considers the current landscape of women’s health, covering recent debates and ongoing issues within the reproductive health sphere …

Feature

GSK shares data from phase 3 trial for Jemperli combinations for endometrial cancer treatment

March 18, 2024
Research and Development GSK, Jemperli, Oncology, clinical trial, endometrial cancer, women's health

GSK has announced positive results from part 1 and part 2 of its RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial for Jemperli (dostarlimab) …

News

Merck shares results for Keytruda in cervical cancer treatment

March 18, 2024
Research and Development Merck, Oncology, cervical cancer, keytruda, women's health

Merck, known as MSD outside of the US and Canada, has announced positive results from the phase 3 KEYNOTE-A18 trial, …

News

NICE recommends that all women should do pelvic floor exercises

June 29, 2021
Manufacturing and Production NHS, NICE, pelvic floor, women's health

NICE has recommended in draft guidance that girls as young as 12 should be encouraged to do pelvic floor muscle …

News
teva_copy

Teva completes sale of women’s health for $1.38 billion

September 19, 2017
Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical, women's health

Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025